The effect of folic acid administration on cardiac tissue matrix metalloproteinase activity and hepatorenal biomarkers in diabetic rats1

Diabetes mellitus (DM) is a metabolic disorder that causes severe complications. Thus, the aims of this study were to investigate the influence of DM and folic acid treatment on liver and renal biomarkers, and heart remodeling through evaluation of cardiac matrix metalloproteinase (MMP) activity. Th...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of physiology and pharmacology Vol. 97; no. 9; pp. 893 - 901
Main Authors Mutavdzin, Slavica, Gopcevic, Kristina, Stankovic, Sanja, Jakovljevic Uzelac, Jovana, Labudovic Borovic, Milica, Djuric, Dragan
Format Journal Article
LanguageEnglish
Published NRC Research Press 2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diabetes mellitus (DM) is a metabolic disorder that causes severe complications. Thus, the aims of this study were to investigate the influence of DM and folic acid treatment on liver and renal biomarkers, and heart remodeling through evaluation of cardiac matrix metalloproteinase (MMP) activity. There were 4 groups: control (physiological saline 1 mL/kg, i.p., 28 days), DM (streptozotocin [STZ] 100 mg/kg in physiological saline, i.p., 1 day), folic acid (FA; 5 mg/kg, i.p., 28 days), and DM+FA (STZ 100 mg/kg, i.p., 1 day and folic acid 5 mg/kg, i.p., 28 days). Our results demonstrated increased aminotransferase and alkaline phosphatase activity, urea and creatinine concentration, and decreased albumin and fibrinogen concentration in the DM group. MMP-2 relative activity was elevated in the DM and FA groups; MMP-9 was decreased in the DM and increased in the FA group. The folic acid treatment of diabetic rats did not change aminotransferase activity; it alleviated the increase in alkaline phosphatase and the decrease in albumin and fibrinogen concentration, and reduced MMP-2 activity; however, it increased urea and creatinine concentration. In conclusion, folic acid treatment of diabetic rats has cardio- and hepato-protective effects. However, its dosing should be carefully considered because of possible renal damage.
AbstractList Diabetes mellitus (DM) is a metabolic disorder that causes severe complications. Thus, the aims of this study were to investigate the influence of DM and folic acid treatment on liver and renal biomarkers, and heart remodeling through evaluation of cardiac matrix metalloproteinase (MMP) activity. There were 4 groups: control (physiological saline 1 mL/kg, i.p., 28 days), DM (streptozotocin [STZ] 100 mg/kg in physiological saline, i.p., 1 day), folic acid (FA; 5 mg/kg, i.p., 28 days), and DM+FA (STZ 100 mg/kg, i.p., 1 day and folic acid 5 mg/kg, i.p., 28 days). Our results demonstrated increased aminotransferase and alkaline phosphatase activity, urea and creatinine concentration, and decreased albumin and fibrinogen concentration in the DM group. MMP-2 relative activity was elevated in the DM and FA groups; MMP-9 was decreased in the DM and increased in the FA group. The folic acid treatment of diabetic rats did not change aminotransferase activity; it alleviated the increase in alkaline phosphatase and the decrease in albumin and fibrinogen concentration, and reduced MMP-2 activity; however, it increased urea and creatinine concentration. In conclusion, folic acid treatment of diabetic rats has cardio- and hepato-protective effects. However, its dosing should be carefully considered because of possible renal damage.
Abstract_FL Le diabète sucré (DS) est une maladie métabolique qui cause des complications graves. Par conséquent, ces travaux avaient pour but d’étudier l’influence du DS et de l’administration d’acide folique (AF) sur les biomarqueurs hépatiques et rénaux, ainsi que sur le remodelage du cœur à l’aide de l’évaluation de l’activité des métalloprotéinases matricielles cardiaques. Nous avons formé 4 groupes : témoin (solution physiologique à 1 ml/kg, i.p. pendant 28 jours), DS (streptozotocine [STZ] à 100 mg/kg dans une solution physiologique, i.p. pendant 1 jour), AF (à 5 mg/kg dans une solution physiologique, i.p. pendant 28 jours) et DS + AF (STZ à 100 mg/kg dans une solution physiologique, i.p. pendant 1 jour et AF à 5 mg/kg dans une solution physiologique, i.p. pendant 28 jours). Nos résultats ont montré une hausse de l’activité des aminotransférases et de la phosphatase alcaline, des concentrations d’urée et de créatinine, ainsi qu’un abaissement des concentrations d’albumine et de fibrinogène dans le groupe DS. Nous avons observé une hausse de l’activité relative de la MMP-2 dans les groupes DS et AF, ainsi qu’un abaissement de la MMP-9 dans le groupe DS, mais une hausse dans le groupe AF. L’administration AF n’a pas entraîné de modification de l’activité des aminotransférases chez les rats diabétiques : il entraînait une atténuation de la hausse de la phosphatase alcaline, ainsi qu’un abaissement des concentrations d’albumine et de fibrinogène, avec une diminution de l’activité de la MMP-2; il entraînait toutefois une hausse des concentrations d’urée et de créatinine. En conclusion, l’administration AF permet d’obtenir des effets cardio- et hépatoprotecteurs chez des rats diabétiques. Cependant, il faudrait entreprendre une augmentation des doses AF avec prudence en raison de la possibilité d’observer des lésions rénales. [Traduit par la Rédaction]
Author Djuric, Dragan
Jakovljevic Uzelac, Jovana
Stankovic, Sanja
Labudovic Borovic, Milica
Gopcevic, Kristina
Mutavdzin, Slavica
Author_xml – sequence: 1
  givenname: Slavica
  surname: Mutavdzin
  fullname: Mutavdzin, Slavica
  organization: Institute of Medical Physiology “Richard Burian”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 2
  givenname: Kristina
  surname: Gopcevic
  fullname: Gopcevic, Kristina
  organization: Institute of Chemistry in Medicine “Prof. Dr. Petar Matavulj”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 3
  givenname: Sanja
  surname: Stankovic
  fullname: Stankovic, Sanja
  organization: Centre of Medical Biochemistry, Clinical Centre of Serbia, Belgrade, Serbia
– sequence: 4
  givenname: Jovana
  surname: Jakovljevic Uzelac
  fullname: Jakovljevic Uzelac, Jovana
  organization: Institute of Medical Physiology “Richard Burian”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 5
  givenname: Milica
  surname: Labudovic Borovic
  fullname: Labudovic Borovic, Milica
  organization: Institute of Histology and Embryology “Aleksandar Dj. Kostic”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
– sequence: 6
  givenname: Dragan
  surname: Djuric
  fullname: Djuric, Dragan
  organization: Institute of Medical Physiology “Richard Burian”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia
BookMark eNqdj8FOwzAQRC1UJFrgynl_IGAnLU3PCMQH9G5tnY2yJbGj9YLoH_DZOBJfgDTSaA4zo7cxq5giGfPg7KNzzeEpnOe5qq07VNbW-yuzdrXdVfvd1q3M2lrbVtva1Tdmk_O5xOe2adfm5zgQUN9TUEg99GnkABi4A-wmjpxVUDlFKAooHWMA5Zw_CSZU4W-YSHEc0yxJiSNmKnXlL9YLYOxgoBk1CUUc4cRpQvkgycARytaJtNyVh-zuzHWPY6b7P7817u31-PJeRQlCmVDC4GfhMnDxzvoF2S_IfkH2C3Lzn84vSORmFg
ContentType Journal Article
DOI 10.1139/cjpp-2019-0027
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1205-7541
EndPage 901
ExternalDocumentID cjpp-2019-0027
GroupedDBID -
08R
0R
1AW
29B
2QV
3O-
3V.
4.4
53G
55
5GY
5RE
5RP
7RV
7X7
88A
88E
88I
8AF
8AO
8FE
8FH
8FI
8FJ
8FQ
AALRV
ABDBF
ABFLS
ABPTK
ABUFD
ABUWG
ACGFS
ACGOD
ACIWK
ACKIV
ACPRK
ADBBV
ADKZR
AENEX
AFFNX
AFKRA
AFRAH
AHMBA
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBAFP
BBNVY
BCGST
BCR
BENPR
BES
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CAG
COF
CS3
D8U
DU5
DWQXO
DXH
EAD
EAP
EAS
EBD
EBS
ECC
EDH
EJD
EMB
EMK
EPL
ESX
EX3
F5P
FYUFA
GJ
GNUQQ
HCIFZ
HZ
IAO
ICQ
IEA
IHR
INH
INR
IOF
IPY
ISN
ISR
ITC
L7B
LK8
M0L
M1P
M2P
M2Q
M3C
M3E
M3G
M7P
MV1
MVM
NMEPN
NRXXU
NYCZX
O9-
OVD
P2P
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QF4
QM4
QN7
QO4
QRP
RIG
RRCRK
RRP
SV3
TUS
UAP
WH7
WOW
X
X7M
ZGI
ZXP
ID FETCH-nrcresearch_primary_10_1139_cjpp_2019_00273
ISSN 0008-4212
IngestDate Wed Nov 11 00:33:26 EST 2020
IsPeerReviewed true
IsScholarly false
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-nrcresearch_primary_10_1139_cjpp_2019_00273
ParticipantIDs nrcresearch_primary_10_1139_cjpp_2019_0027
PublicationCentury 2000
PublicationDate 20190000
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 20190000
PublicationDecade 2010
PublicationTitle Canadian journal of physiology and pharmacology
PublicationYear 2019
Publisher NRC Research Press
Publisher_xml – name: NRC Research Press
SSID ssj0006838
Score 3.7228928
Snippet Diabetes mellitus (DM) is a metabolic disorder that causes severe complications. Thus, the aims of this study were to investigate the influence of DM and folic...
SourceID nrcresearch
SourceType Publisher
StartPage 893
SubjectTerms cardiac remodelling
diabetes mellitus
diabète sucré
dommages hépatiques
dommages rénaux
hepatic damage
matrix metalloproteinases
métalloprotéinases matricielles
rat
remodelage cardiaque
renal damage
Title The effect of folic acid administration on cardiac tissue matrix metalloproteinase activity and hepatorenal biomarkers in diabetic rats1
URI http://www.nrcresearchpress.com/doi/abs/10.1139/cjpp-2019-0027
Volume 97
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF6l4VIOVQut-tYcKg41buNXHB8DLUVIRagEiZu1WdYiaXCs4KCSX9Cf2J_TmR3HXoseoFJkRbvO2tr5Mq-d_VaID-iES60i5cow0W6Y-BL_UmHsyijToeqN0SRSoPj9uH94Fh6dR-edzh-ramlZjj-p1T_3lfyPVLEN5Uq7ZB8g2XpQbMDvKF-8ooTxem8Zc0EG-XwZUfw6Uk0uHNmixKUFAWWQoJzSTLRzRcz8v-j8aFp4N2QNkxwNmuHWMMdJUEL9Em0VxuSaPFbap0-lPAsuoDUpW6J_luW1Z3u4Nd2BxUlh0icN2VPR0GU3NcjLUt5crJjR4HQmb6waom_zQqH9Vo1Syus-OgX557zqPJX5tO45ktg-m9IPnbOVnknFqwV0irSd67B06fGP_boUsVWcwkp94NLCNps01uN-L3LjiDm11oqeC4ErQCeW1h7wIY2VA5BwduWubQmImlVNi8Kld3Mpom-saF3b2L7hkdjwY4xBu2JjuPdl76D2EvqDgL2E6uUrQlF8yOf2CJtiM1-oivrp0nJ-Rk_FkypqgSFD8Jno6HxLbA9zRMfVLezASS3gLbFzwuK93YVRs7nvetfc1gh-W_zGbmD4wjwDA18g-EIbvoCfCr7A8AWGL9yBL6zhC4gzsOALDXxhksMavmDg-1x4B19H-4euNQNpwTQsqQlfgySl6UppulJDzvRCdPN5rl8KCDylzMpirL0w83Xih0HmZf2w31PjQZy9Eh_vP-7rh9z8Rjxm-VGq7q3oloulfofOazl-X-HgLw72rNM
link.rule.ids 315,786,790,4043,27956,27957,27958
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+effect+of+folic+acid+administration+on+cardiac+tissue+matrix+metalloproteinase+activity+and+hepatorenal+biomarkers+in+diabetic+rats1&rft.jtitle=Canadian+journal+of+physiology+and+pharmacology&rft.au=Mutavdzin%2C+Slavica&rft.au=Gopcevic%2C+Kristina&rft.au=Stankovic%2C+Sanja&rft.au=Jakovljevic+Uzelac%2C+Jovana&rft.date=2019&rft.pub=NRC+Research+Press&rft.issn=0008-4212&rft.eissn=1205-7541&rft.volume=97&rft.issue=9&rft.spage=893&rft.epage=901&rft_id=info:doi/10.1139%2Fcjpp-2019-0027&rft.externalDocID=cjpp-2019-0027
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-4212&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-4212&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-4212&client=summon